Consumer Packaged Goods & Pharmaceuticals · Advertiser / Brand
HERMES ARZNEIMITTEL
German OTC pharmaceuticals and consumer health brand company.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- HERMES ARZNEIMITTEL GmbH
- Entity type
- COMPANY
- Founded
- 1907
- Headquarters
- Germany
- Company size
- 50–200
- Market cluster / sector
- Consumer Packaged Goods & Pharmaceuticals
- Market role
- Advertiser / Brand
- Official website
- hermes-arzneimittel.com
What HERMES ARZNEIMITTEL does
The company creates value by owning and managing a portfolio of OTC healthcare brands, developing and manufacturing formulations, and distributing them through pharmacy-led channels and export partners. Its model combines brand building, regulated product commercialisation, channel management and international distribution, with portfolio expansion through acquisitions of established OTC assets.
Category differentiation
This is a German OTC pharmaceuticals and consumer-health company, not a logistics firm, courier brand or adtech platform. It sells healthcare products through pharmacies and export partners rather than software or media services.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
HERMES ARZNEIMITTEL GmbH is a German consumer-health and pharmaceutical company focused on over-the-counter medicines, dietary supplements and related health brands. It develops, manufactures, markets and distributes more than 30 OTC brands, primarily through pharmacies in Germany and through export partners in roughly 25 countries. The company operates as part of the HERMES Group under the Johannes Burges Family Foundation. The company generates revenue from product sales across its owned and managed OTC portfolio, supported by pharmacy-channel relationships, brand lifecycle management and selected portfolio acquisitions. Its direct customers are pharmacies, healthcare retailers and international distribution partners, while end consumers are reached through those channels. Hermes Experts extends this model with a professional information portal for pharmacists, supporting sell-through and advisory quality rather than acting as a standalone software business.
Business model & monetisation
HERMES ARZNEIMITTEL monetises through wholesale and channel sales of OTC medicines, supplements and consumer health products under proprietary and acquired brands. Revenue is driven mainly by physical product sales, supported by export distribution agreements and brand portfolio management. The Hermes Experts portal functions as a channel-enablement asset rather than a separate SaaS revenue line.
- OTC product portfolio sales
- Retail Margin
- International export distribution
- Retail Margin
- Third-party distribution and brand partnership activity
- Service Fee
Products & capabilities
No products with linked sources are available in this view.
Unlock Full Intelligence Profile for HERMES ARZNEIMITTEL
Get unlimited access to corporate ownership, historical M&A transactions, verified tech stack telemetry, and live market signals in the interactive Knowledge Graph.
Verified Ownership & Corporate Hierarchy
Complete corporate hierarchy traversal, shareholder cap table history, and parent holding links sourced from regulatory filings.
360° Tech Stack & Vendor Telemetry
Technical header bidding configurations, sellers.json registry nodes, CMP disclosures, and direct programmatic supply chains.
Live Market Signals & Executive Briefings
Continuous 24/7 monitoring of material M&A deals, executive shifts, product rollouts, and hiring trends across peer entities.
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Havas Retains Hermes Arzneimittel Media Account
Agency & Consultancy · Recorded impact score: 2/5
Havas Media’s Frankfurt office has been confirmed as Hermes Arzneimittel’s media agency after winning a multi-stage pitch. From 2027 the agency will take responsibility for the full media budget — including digital activities — in an assignment valued in the mid single-digit million euro range. Havas, which has served Hermes since 2013, will assume additional brand duties that, together with digital responsibilities, will double the media volume it manages for the client. Hermes’ brands cited include Antibrumm (Anti Brumm), Compeed (blister plasters), Algorvir (algovir), Biolectra Magnesium, Betaisodona and doc. The win was reported by Horizont on 17 August 2026.
- Havas Media (Frankfurt) won Hermes Arzneimittel’s full media account following a multi-stage pitch.
- Havas will assume responsibility for the account from 2027, including digital activities.
Explore company relationships
Questions about HERMES ARZNEIMITTEL
What is HERMES ARZNEIMITTEL?
HERMES ARZNEIMITTEL is a German pharmaceutical and consumer-health company that develops, manufactures, markets and distributes OTC medicines and health brands.
Who uses HERMES ARZNEIMITTEL?
Its direct customers are pharmacies, healthcare retailers and international distribution partners, while pharmacists also use its professional information portal.
How does HERMES ARZNEIMITTEL make money?
It makes money mainly from selling OTC medicines, supplements and consumer health products through pharmacy channels and export partnerships.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
15 publicly documented primary sources and citations linked across the market graph.
Continue your research on HERMES ARZNEIMITTEL
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.
Unlock full intelligence profile, ownership & live market signals